文献速递眼底病与葡萄膜炎

选择性STING抑制剂H-151可能用于治疗新生血管性年龄相关性黄斑变性

H-151, a Selective STING Inhibitor, Has Potential as a Treatment for Neovascular Age-Related Macular Degeneration.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2024-01-01

本研究在小鼠激光诱导脉络膜新生血管(CNV)模型中评价STING抑制剂H-151的作用。CNV诱导后视网膜色素上皮-脉络膜复合体中cGAS和STING表达显著上调,玻璃体内注射H-151可抑制CNV发展和新生血管荧光渗漏,并减弱cGAS-STING通路下游信号。

要点

  • 激光诱导CNV后小鼠RPE-脉络膜复合体中cGAS和STING表达显著上调。
  • 玻璃体内注射H-151可抑制小鼠CNV发展和新生血管荧光渗漏。
  • H-151减弱cGAS-STING通路下游信号并下调白细胞介素1β表达。

核心结论

  • 研究结果支持抑制cGAS-STING通路可治疗异常眼内血管生成。

研究设计与样本

  • 研究在雄性C57BL/6J小鼠中采用激光光凝诱导CNV,并用蛋白质印迹法确认CNV发展过程中cGAS和STING的表达变化。
  • H-151作为一种强效STING棕榈酰化拮抗剂被用作STING抑制剂,在激光诱导后立即经玻璃体内给药。
  • 为确认cGAS-STING通路在CNV形成中的作用,研究评估了CNV大小并进行了眼底荧光素血管造影。

主要发现

  • CNV诱导后,RPE-脉络膜复合体中cGAS和STING的表达水平显著上调,且在CNV病灶中观察到dsDNA与cGAS共定位。
  • 玻璃体内给予H-151抑制了CNV发展和新生血管的荧光渗漏。
  • 在CNV病灶中,浸润的F4/80+巨噬细胞高表达STING和cGAS。
  • 给予H-151减弱了cGAS-STING通路的下游信号,包括核因子-κB的磷酸化,并下调了白细胞介素1β的表达。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The cyclic guanosine monophosphate-adenosine monophosphate synthase (cGAS) stimulator of interferon gene (STING) pathway is a crucial cascade in the inflammatory response initiated by the recognition of cytosolic double-stranded DNA (dsDNA). The aim of this study was to evaluate the effect of STING inhibitor in murine choroidal neovascularization (CNV). METHODS: To investigate whether the cGAS-STING pathway is activated during CNV, CNV was induced using laser photocoagulation in male C57BL/6J mice. The expression of change of cGAS and STING during CNV development was confirmed by Western-blotting. H-151, a potent STING palmitoylation antagonist, was used as a STING inhibitor. H-151 was administered intravitreally immediately after laser induction. To confirm the role of the cGAS-STING pathway in CNV formation, we evaluated CNV size and performed fundus fluorescein angiography. RESULTS: The expression levels of cGAS and STING were significantly upregulated in the RPE-choroid complex after CNV induction, and dsDNA merged with cGAS was observed in CNV lesions. Intravitreal administration of H-151 suppressed CNV development and fluorescent leakage from neovessels. In CNV lesions, the high expression of STING and cGAS was observed in infiltrating F4/80+ macrophages. H-151 administration attenuated downstream signals of the cGAS-STING pathway, including the phosphorylation of nuclear factor-κB, and downregulated the expression of interleukin 1β. CONCLUSIONS: These findings support that the inhibition of cGAS-STING pathway treats abnormal ocular angiogenesis.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Tanaka M, Yasuda H, Nakamura S, et al. H-151, a Selective STING Inhibitor, Has Potential as a Treatment for Neovascular Age-Related Macular Degeneration. Invest Ophthalmol Vis Sci. 2024. PMID: 38980271. doi:10.1167/iovs.65.8.16

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。